Tiziana Life Stock London S.E.
Equities
TILS
GB00BKWNZY55
Biotechnology & Medical Research
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 60.66M |
---|---|---|---|---|---|
Net income 2021 | -23M | Net income 2022 | -15M | EV / Sales 2021 | - |
Net cash position 2021 | 42.19M | Net cash position 2022 | 17.76M | EV / Sales 2022 | - |
P/E ratio 2021 |
-4.01
x | P/E ratio 2022 |
-3.95
x | Employees | 9 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 32.56% |
Latest transcript on Tiziana Life
Managers | Title | Age | Since |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 20-06-30 |
Willy Simon
BRD | Director/Board Member | 72 | 15-10-31 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.84B | |
+46.34% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |